Plain-English translation of NCT07363642 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a new medication called can help people with severe asthma reduce the number and doses of other medications they take daily. Right now, most people with severe asthma need to take multiple medications at higher doses to stay well. This trial wants to see if this medication works well enough that patients can safely step down their other treatments while staying healthy.
Many people with severe asthma struggle with side effects or the burden of taking multiple high-dose medications every day. This trial is designed to find out whether this medication is powerful enough to let patients take fewer or lower-dose treatments while still keeping their asthma controlled.
You likely qualify if…
You likely don't qualify if…
Over about one year, you will visit the study clinic approximately 70 times across China at one of many participating centers. You will receive injections of the new medication and be monitored closely as your doctor carefully reduces your other asthma medications if your asthma stays well controlled. The study team will track your symptoms, asthma attacks, lung function, and overall safety throughout the year.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
China